Related Experiment Video
Updated: Jan 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Inflammatory Bowel Disease in Children and Young People Living With Overweight or Obesity: A Critical Narrative
Razan Algarni1,2, Efstathia Papada1, Adrian Brown3,4,5
1Division of Medicine, University College London, London, UK.
Insights
Overweight and obesity contribute to inflammatory bowel disease (IBD) development and progression in young people. Increased adiposity worsens IBD through inflammation, microbiota imbalance, and nutrient deficiencies, necessitating weight management interventions.
Area of Science:
- Pediatric Gastroenterology
- Obesity Research
- Inflammatory Bowel Disease
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic gastrointestinal inflammatory disorder.
- Global IBD prevalence has risen alongside increasing rates of overweight and obesity in children and adolescents.
- Approximately 24% of pediatric IBD patients are overweight or obese, predominantly with ulcerative colitis.
Purpose of the Study:
- To critically review the contribution of overweight and obesity to IBD development and disease course in pediatric populations.
- To elucidate mechanistic pathways linking increased adiposity to IBD pathogenesis.
- To discuss weight management interventions for overweight/obese children and young people with IBD.
Main Methods:
- This study is a critical narrative review of existing literature.
- Mechanistic pathways were explored based on current scientific understanding.
- Relevant research on IBD, obesity, and pediatric populations was synthesized.
Main Results:
- Increased adiposity is linked to heightened disease activity and adverse outcomes in pediatric IBD.
- Obesity contributes to IBD pathogenesis via increased proinflammatory cytokines, microbiota imbalance, and heightened intestinal permeability.
- Adiposity exacerbates micronutrient deficiencies (e.g., iron, vitamin D) and is associated with increased disease activity.
Conclusions:
- Overweight and obesity negatively impact pediatric inflammatory bowel disease, affecting disease development and course.
- Urgent research is needed to fully understand these impacts and guide effective, tailored interventions.
- Weight management strategies are crucial for improving outcomes in overweight/obese pediatric IBD patients.
Abstract:
Inflammatory bowel disease is a chronic inflammatory disorder affecting the gastrointestinal tract. It mainly comprises of Crohn's disease and ulcerative colitis. Its global prevalence has risen simultaneously with overweight and obesity among children and young people over the last decades. This critical narrative review aims to explore how living with overweight or obesity contributes to the development of inflammatory bowel disease (IBD) as well as the disease course in children and young people. Approximately, 24% of children and young people with the disease are living with overweight or obesity, with the majority being diagnosed with ulcerative colitis. Obesity appears to be associated with increased disease activity, adverse effects, with increased adiposity contributing to IBD pathogenesis though multiple mechanisms. Here, we offer a novel mechanistic pathway to how obesity impacts on IBD pathogenesis. Increased adiposity appears to contribute to its pathogenesis through increased proinflammatory cytokines and microbiota imbalance leading to inflammation and increased intestinal permeability. Additionally, adiposity appears to exacerbate micronutrient deficiencies associated with inflammatory bowel disease, including iron and vitamin D. Obesity is also shown to be associated with increased disease activity. Finally, we review possible weight management interventions available to children and young people living with obesity and overweight and IBD. In conclusion, living with overweight and obesity are proposed to have adverse effects on inflammatory bowel disease in children and young people, with an urgent need for greater research to better understand their impacts and assist in guiding effective tailored interventions.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Obesity
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

